BPA Call W91YTZ23A0014-W91YTZ24F0141
Award Date
8/1/24
Potential Completion Date
8/15/24
Potential Value
$16K
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Medical Command
Awardee
Cerilliant Corporation
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Fort Meade, MD 20755, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a Blanket Purchase Agreement (BPA) call issued by the Defense Health Agency (DHA) to Cerilliant Corporation, a global leader in certified reference materials and laboratory supplies. The contract, valued at $8,279.36, is for the provision of drug reference standards to support the DHA's drug screening and testing programs for service members. Cerilliant Corporation is a foreign-owned, for-profit manufacturer based in Texas, with over 30 years of experience as a...
This federal contract award is a BPA (Blanket Purchase Agreement) call for drug reference standards and related supplies from Cerilliant Corporation, a global leader in certified reference materials. The contract has a total ceiling value of $9,906.25 and is awarded to Cerilliant by the Defense Health Agency (DHA), a defense agency within the Department of Defense. The contract delivers drug reference standards, calibrators, reagents, and laboratory materials to support research, testing,...
This federal contract award was issued by the Defense Health Agency (DHA) to Cerilliant Corporation, a global leader in certified reference materials. The $17,226.00 Blanket Purchase Agreement (BPA) Call contract is for the supply of FTDTL CERILLIANT SUPPLIES-MEADE, which are drug reference standards used for screening and confirmation testing of service member specimens. Cerilliant, a foreign-owned, for-profit manufacturer, has a strong track record of providing analytical standards and...
This federal contract award to Cerilliant Corporation, a foreign-owned manufacturer based in Round Rock, Texas, is for the supply of drug standards used for screening and confirmation testing of urine, blood, and tissue samples from service members suspected of drug use. The $10,010.88 firm fixed-price contract is a Blanket Purchase Agreement (BPA) call with the Defense Health Agency (DHA), a defense agency. Cerilliant, which has over 30 years of experience as a government contractor, will...
This is a federal contract award to Cerilliant Corporation, a foreign-owned, for-profit manufacturer of chemical and biological reference materials based in Round Rock, Texas. The contract, awarded by the Defense Health Agency (DHA), is for the provision of medical supplies. The contract is a Blanket Purchase Agreement (BPA) call, with a firm fixed-price pricing type and a ceiling value of $32,348.38. The contract is set to expire on September 30, 2023. Cerilliant Corporation has a history of...
This firm fixed-price contract award to Cerilliant Corporation, a foreign-owned for-profit manufacturer, is for the provision of drug standards that will be used for screening and testing of service members' specimens. The contract, valued at $12,538.24, was awarded by the Defense Health Agency on March 26, 2024, with a completion date of September 30, 2024. This appears to be a call under a larger Blanket Purchase Agreement (BPA) vehicle, as the contract type is listed as "BPA...
Cerilliant Corporation was awarded a firm fixed price call against the Blanket Purchase Agreement with the Defense Health Agency with a potential value of $19,158.95. The contract is for the provision of reference standards, reagents, calibrators and other laboratory materials to support testing and healthcare programs at Fort Meade, Maryland. No set aside designation was applied. Cerilliant is a global leader in supplying chemical and biological reference standards to federal agencies. They...
This is a Firm Fixed Price contract awarded by the Defense Health Agency (DHA) to Cerilliant Corporation, a global manufacturer of certified reference materials and analytical standards. The contract, valued at $22,803.21, is for the provision of drug screening and confirmation testing services for suspected drug use in service member investigative and/or post-mortem urine, blood, and tissue samples. The contract has an ultimate completion date of September 30, 2025. Cerilliant Corporation, a...
<p>Cerilliant Corporation was awarded a firm fixed price blanket purchase agreement (BPA) call contract by the Defense Health Agency on April 24, 2023. The potential value of the contract is $2,100 to provide products and services under BPA N-012/N-012 1ML in support of the Defense Health Agency's programs. Performance will take place in Fort Meade, Maryland with an completion date of April 24, 2023. No set-aside designation was used for this award.</p>
This firm-fixed-price purchase order contract was awarded by the Bureau of Medicine and Surgery (a part of the U.S. Department of Defense) to Cerilliant Corporation, a foreign-owned, for-profit manufacturer of chemical and biological reference standards based in Round Rock, Texas. The $76,775.55 contract does not have a set-aside designation. Cerilliant has a history of providing essential reference materials and analytical standards to support various government healthcare, research, and...